Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Aberg

Showing results (101-110 of 211) with videos related to

Pageof 22
Sort By:
Science Advances|June 18, 2019
Targeting thrombogenicity and inflammation in chronic HIV infectionMeagan P O'Brien, M Urooj Zafar, Jose C Rodriguez, et al.
Antiviral Research|January 31, 2025
High HIV-1 viremia and low anti-Env antibody responses are associated with delayed treatment response to fostemsavir in highly treatment-experienced individualsSvenja Weiss, Raymond A Alvarez, Marisa Goff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2003
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials GroupMichael P Dubé, James H Stein, Judith A Aberg, et al.
Papillomavirus Research (Amsterdam, Netherlands)|August 18, 2018
Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1Michelle S Cespedes, Minhee Kang, Erna Milunka Kojic, et al.
Vaccine|September 17, 2022
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulationsJuan Manuel Carreño, Gagandeep Singh, Johnstone Tcheou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2017
Assessing Antiretroviral Use During Gaps in HIV Primary Care Using Multisite Medicaid Claims and Clinical DataAnne K Monroe, John A Fleishman, Cindy C Voss, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 5, 2017
Gonorrhea and Chlamydia Case Detection Increased When Testing Increased in a Multisite US HIV Cohort, 2004-2014Julia R Raifman, Kelly A Gebo, William Christopher Mathews, et al.
Plos One|July 7, 2015
High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial GroupCaroline H Shiboski, Huichao Chen, Rode Secours, et al.
Cancer Medicine|September 18, 2020
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer PatientsDouglas Tremblay, Carina Seah, Thomas Schneider, et al.
Ebiomedicine|September 4, 2018
Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trialMabel Toribio, Kathleen V Fitch, Lauren Stone, et al.
Pageof 22

Showing results (101-110 of 211) with videos related to

Sort By:
Pageof 22
Science Advances|June 18, 2019
Targeting thrombogenicity and inflammation in chronic HIV infectionMeagan P O'Brien, M Urooj Zafar, Jose C Rodriguez, et al.
Antiviral Research|January 31, 2025
High HIV-1 viremia and low anti-Env antibody responses are associated with delayed treatment response to fostemsavir in highly treatment-experienced individualsSvenja Weiss, Raymond A Alvarez, Marisa Goff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2003
Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials GroupMichael P Dubé, James H Stein, Judith A Aberg, et al.
Papillomavirus Research (Amsterdam, Netherlands)|August 18, 2018
Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1Michelle S Cespedes, Minhee Kang, Erna Milunka Kojic, et al.
Vaccine|September 17, 2022
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulationsJuan Manuel Carreño, Gagandeep Singh, Johnstone Tcheou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 11, 2017
Assessing Antiretroviral Use During Gaps in HIV Primary Care Using Multisite Medicaid Claims and Clinical DataAnne K Monroe, John A Fleishman, Cindy C Voss, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 5, 2017
Gonorrhea and Chlamydia Case Detection Increased When Testing Increased in a Multisite US HIV Cohort, 2004-2014Julia R Raifman, Kelly A Gebo, William Christopher Mathews, et al.
Plos One|July 7, 2015
High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial GroupCaroline H Shiboski, Huichao Chen, Rode Secours, et al.
Cancer Medicine|September 18, 2020
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer PatientsDouglas Tremblay, Carina Seah, Thomas Schneider, et al.
Ebiomedicine|September 4, 2018
Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trialMabel Toribio, Kathleen V Fitch, Lauren Stone, et al.
Pageof 22